< Back

Walther Seiler

Bayer HealthCare AG
PhD, Editor in the Life Sciences
Leader background:
After a classical education as a zoologist, Walther Seiler gained his PhD in neuroendocrinology at the University of Mainz, Germany. Throughout his academic career, he enjoyed interpreting and presenting data at least as much as generating them, so medical writing was a logical career step.  After several years of medical writing in an international CRO, Walther moved to a global pharma company, overall gaining 25 years of medical writing experience.  Clinical study protocols (CSPs) soon caught Walther’s interest because they form the basis for many important downstream clinical documents.  For many years, Walther has been involved in the development and maintenance of his company’s CSP template
The Clinical Study Protocol: Content and Structure
    Level: Foundation Area: Drug development
    Code: DDF12 Duration: 03:30:00
Protocol Amendments
    Level: Foundation Area: Drug Development
    Code: DDF29 Duration: 03:00:00
Templates for Clinical Study Protocols: Current Position within the Industry
    Level: Area: Expert Seminar Series Session 3 Regulatory
    Code: ESS21 Duration: 01:30:00